Recent Announcements
ASX Announcement, 3 July 2008
Completion of Settlement of the IP Agreement
3 July 2008, Sydney, Australia: Medical Therapies Limited (ASX: MTY), announced today that it has completed Settlement pursuant to its Intellectual Property Agreement with Cell Signals Inc for the acquisition of the Midkine protein related technology assets.
To find out more ...- download pdf here
ASX Announcement, 16 April 2008
Medical Therapies Signs Agreement For The Acquisition of Platform Technology
16th April 2008, Sydney, Australia: Medical Therapies Limited (ASX: MTY), announced today that it has entered into an Intellectual Property Agreement with Cell Signals Inc, covering the acquisition of a large portfolio of assets relating to the use of midkine in therapeutic and diagnostic applications.
To find out more ...- download pdf here
ASX Announcement, 15th February 2008
Positive Clinical Interim Results
15th February 2008, Sydney, Australia: Medical Therapies Limited (ASX: MTY), today announced that it has completed its ‘first-in-human’ clinical trial of Cuprindo™ to determine its safety, tolerability and systemic absorption characteristics. The Phase 1 trial was conducted using a topical suppository formulation in preparation for a planned efficacy study in proctitis patients.
To find out more ... - download pdf here
ASX Announcement, 1st February 2008
Commencing Human Clinical Trials of Cuprindo™
1st February 2008, Sydney, Australia: Medical Therapies Limited (ASX: MTY), today announced that it has completed recruitment for ‘first in human’ clinical trials of Cuprindo™ to determine its safety, tolerability and systemic absorption characteristics.
To find out more ....- Download pdf here
Latest Shareholder Update, 1st February 2008
Welcome to this second edition of MTY News.
To read more... download a copy of the newsletter here ..